The effect of bevacizumab on vestibular schwannoma tumour size and hearing in patients with neurofibromatosis type 2
Crossref DOI link: https://doi.org/10.1007/s00405-014-3398-3
Published Online: 2014-11-25
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Alanin, Mikkel Christian
Klausen, Camilla
Caye-Thomasen, Per
Thomsen, Carsten
Fugleholm, Kaare
Poulsgaard, Lars
Lassen, Ulrik
Mau-Sorensen, Morten
Hofland, Kenneth Francis
Text and Data Mining valid from 2014-11-25